Cargando…
SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
Patients suffering from autoimmune hepatitis, a chronic immune-mediated liver disease with an incidence of 0.9 to 2 per 100,000 population per year in Europe, are considered to have a particularly increased risk for coronavirus disease 2019 (Covid-19)-associated hospitalization and death.(1,2) Sever...
Autores principales: | Schneider, Lisa, Schubert, Lorenz, Winkler, Florian, Munda, Petra, Winkler, Stefan, Tobudic, Selma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040499/ https://www.ncbi.nlm.nih.gov/pubmed/35487452 http://dx.doi.org/10.1016/j.cgh.2022.04.006 |
Ejemplares similares
-
Renal Abscess: A Rare Complication of Paratyphoid Fever in an Immunocompetent Traveler from Southeast Asia
por: Schubert, Lorenz, et al.
Publicado: (2021) -
Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis
por: Breu, Markus, et al.
Publicado: (2023) -
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
por: Schubert, Lorenz, et al.
Publicado: (2022) -
Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
por: Pokryszka, Jagoda, et al.
Publicado: (2022) -
The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
por: Tobudic, Selma, et al.
Publicado: (2023)